Every 10-Q that BNB PLUS CORP (BNBX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow BNBX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BNBX filings page.
BNB Plus Corp. reports that for the quarter ended June 30, 2026, it is operating as a digital asset treasury company, using BNB cryptocurrency as its primary reserve asset while continuing smaller-scale therapeutic DNA production activities. Total assets rose to $14,964,985 from $4,437,441 at September 30, 2025, driven by digital assets, a $4,526,280 investment in an OBNB digital asset trust, and recent equity financings. Revenue for the nine months reached $2,194,811, mainly from large-scale DNA production, but the company recorded a nine-month net loss of $29,950,919, including sizeable fair value losses on BNB and the OBNB trust plus warrant-related expenses and high selling, general and administrative costs.
Net cash used in operating activities from continuing operations was $8,577,673, while financing activities provided $12,907,885, reflecting private placements of Series B-1 and B-2 convertible preferred stock and warrants, exercises of existing warrants, and ATM share sales. Cash and cash equivalents were $3,761,482 at June 30, 2026, and management states that existing cash, plus liquid cryptocurrency, are expected to fund operations for at least twelve months. On the capital markets side, BNB Plus common stock was delisted from Nasdaq in July 2026 for not meeting the minimum bid price and now trades on the OTCQB Venture Market under the symbol BNBX.
BNB Plus Corp. reported a sharp increase in losses as it pivoted to a digital asset treasury strategy centered on BNB tokens. For the quarter ended March 31, 2026, revenue rose to $1.0 million, mainly from therapeutic DNA production, but operating expenses reached $7.6 million, including restructuring costs and large consulting and advisory fees tied to its crypto strategy.
The company booked sizeable non‑cash losses from fair value changes in digital assets and its OBNB trust investment, driving a quarterly net loss attributable to common stockholders of $6.7 million and a six‑month loss of $25.3 million. Despite cash of $0.9 million, it holds additional digital assets and trust units and expects current resources and liquid crypto to fund operations for the next twelve months. Subsequent to quarter‑end, BNB Plus received a Nasdaq notice for failing the $1.00 minimum bid price, with its listing status under review.
BNB Plus Corp. (BNBX) reported a sharp widening of its loss as it pivoted to a digital asset treasury model centered on BNB. For the quarter ended December 31, 2025, revenue fell to $565,394 from $870,291, while net loss attributable to common stockholders was $18,626,390 versus $17,546,635 a year earlier, heavily influenced by deemed dividends and new crypto-related charges. Operating expenses surged to $19,023,638, driven by $8.8 million of consultant warrants, $840,585 of additional consultant warrants, higher bonuses and severance, and $5,216,566 of fair value losses on BNB tokens and OBNB Trust Units. The company raised $26.8 million gross in an October 2025 private placement, ending the quarter with total assets of $20,697,042, including $7,130,817 of BNB and $7,950,711 of OBNB Trust Units, and states it expects its cash and liquid crypto to fund operations for the next twelve months.